MTOR and gastric cancer: Notably, dysregulation of the PI3K/AKT/mTOR pathway is well documented to drive diverse oncogenic processes in human tumors, including autophagy, apoptosis evasion, chemotherapy resistance, and metastasis, making it a key therapeutic target for GC treatment via pathway-specific inhibitors [38].